-
Nebraska woman becomes first patient in the world to undergo new MS treatment
06 Aug 2025 20:41 GMT
… . While health officials stress that MS treatment looks different for every patient …
-
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
06 Aug 2025 03:50 GMT
Quantum Biopharma Ltd. QNTM announced on Tuesday that its subsidiary Huge Biopharma Australia has received the clinical study report for a Phase 1, randomized, double-blind, placebo-controlled multiple ascending dose trial evaluating the safety and …
-
When Insurers Restrict MS Drug Coverage, Relapses Rise
06 Aug 2025 12:14 GMT
… exclude coverage of some MS treatments have a significantly higher … to help patients manage their MS, researchers said in background notes. … Medicare Advantage plan.
Since MS drugs aren't included … covered eight of the 15 MS drugs, researchers said.
This …
-
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
05 Aug 2025 11:34 GMT
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today …
-
TG Therapeutics Stock Tumbles 15% After Disappointing Q2, But Company Reaffirms Confidence In Multiple Sclerosis Drug
04 Aug 2025 18:28 GMT
The company raised its Briumvi U.S. net product revenue target to $570 million to $575 million for the full year 2025, up from its previous guidance of $560 million.
TG Therapeutics, Inc. (TGTX) on Monday reaffirmed confidence in its flagship drug Briumvi …
-
Not Getting the MS Drugs You Need? Maybe It’s Because You’re Female
05 Aug 2025 02:42 GMT
…
Pregnancy Can Complicate Multiple Sclerosis Treatment
One big factor weighing … safety and effectiveness of MS drugs during pregnancy, women … stopping or delaying MS treatment might accelerate symptoms … comes to taking MS drugs while pregnant or breastfeeding …
-
Women less likely than men to receive MS drugs, reveals research
04 Aug 2025 21:07 GMT
… in France. “When used early, MS drugs can delay the burden of … on the safety of newer MS drugs, so more work is needed …
-
Exclusions of MS Drugs From Drug Plans Tied to High Relapse Risk
04 Aug 2025 10:01 GMT
… sclerosis (MS), researchers found those in plans with broader coverage of MS treatments had … plans with narrower coverage of MS treatments may be linked to worse … were 15 oral and injectable MS drugs across seven types of “classes …
-
Relapsing-Remitting Multiple Sclerosis Pipeline Insight 2025: Advancing Toward Remission With Next-Gen Immunomodulators And Remyelinating Therapies Delveinsight
08 Aug 2025 03:13 GMT
… drugs for Relapsing-Remitting Multiple Sclerosis treatment.
. The leading Relapsing … improve the Relapsing-Remitting Multiple Sclerosis treatment landscape.
. Key Relapsing … medication at
Relapsing-Remitting Multiple Sclerosis Treatment Analysis: Drug Profile …
-
Merck Delivers Profitable Organic Growth Amid Strong Currency Headwinds
08 Aug 2025 03:09 GMT
… delivered record quarterly sales. The multiple sclerosis drug Rebif recorded an organic net …
About
© 1995-2025